RU2015122882A - PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES - Google Patents

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES Download PDF

Info

Publication number
RU2015122882A
RU2015122882A RU2015122882A RU2015122882A RU2015122882A RU 2015122882 A RU2015122882 A RU 2015122882A RU 2015122882 A RU2015122882 A RU 2015122882A RU 2015122882 A RU2015122882 A RU 2015122882A RU 2015122882 A RU2015122882 A RU 2015122882A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
neuropathies
prevention
treatment
diabetic angiopathies
Prior art date
Application number
RU2015122882A
Other languages
Russian (ru)
Inventor
Борис Игоревич Круглый
Original Assignee
Борис Игоревич Круглый
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Борис Игоревич Круглый filed Critical Борис Игоревич Круглый
Priority to RU2015122882A priority Critical patent/RU2015122882A/en
Publication of RU2015122882A publication Critical patent/RU2015122882A/en

Links

Claims (2)

1. Фармацевтическая композиция для лечения и профилактики диабетических ангиопатий и нейропатий, характеризующаяся тем, что представляет собой гомогенизированную смесь из двух активных фармацевтических субстанций в виде натриевой соли R-стереоизомера альфа-липоевой кислоты и Инозина, при этом соотношение натриевой соли R-стереоизомера альфа-липоевой кислоты к Инозину составляет от 1:10 до 10:1.1. A pharmaceutical composition for the treatment and prevention of diabetic angiopathies and neuropathies, characterized in that it is a homogenized mixture of two active pharmaceutical substances in the form of the sodium salt of the R-stereoisomer of alpha-lipoic acid and Inosine, the ratio of the sodium salt of the R-stereoisomer alpha lipoic acid to Inosine is from 1:10 to 10: 1. 2. Фармацевтическая композиция по п. 1, отличающаяся тем, что дополнительно содержит фармацевтически приемлемые вспомогательные вещества.2. The pharmaceutical composition according to claim 1, characterized in that it further comprises pharmaceutically acceptable excipients.
RU2015122882A 2015-06-16 2015-06-16 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES RU2015122882A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015122882A RU2015122882A (en) 2015-06-16 2015-06-16 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015122882A RU2015122882A (en) 2015-06-16 2015-06-16 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES

Publications (1)

Publication Number Publication Date
RU2015122882A true RU2015122882A (en) 2017-01-10

Family

ID=57955812

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015122882A RU2015122882A (en) 2015-06-16 2015-06-16 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES

Country Status (1)

Country Link
RU (1) RU2015122882A (en)

Similar Documents

Publication Publication Date Title
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
EA201690287A1 (en) 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
EA201592256A1 (en) DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
EA201792592A1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN
EA201792591A1 (en) PHARMACEUTICAL PREPARATIONS
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
MX2021002321A (en) Novel methods.
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
RU2019139886A (en) THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS
MX2020007552A (en) Stable pharmaceutical composition comprising esomeprazole and sodium bicarbonate.
PH12015502406A1 (en) Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof
MX2019003698A (en) Composition comprising at least one water-soluble pharmaceutically acceptable salt of elafibranor having improved intestinal absorption.
EA201590474A1 (en) PHARMACEUTICAL COMPOSITION BASED ON COMPOSITE CAPSULES INCLUDING IRBESARTAN AND HMG-COA REDUCTASE INHIBITOR
EA202090164A1 (en) Isotretinoin oral-mucous compositions and methods for their use
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
EA201891860A1 (en) PHARMACEUTICAL COMPOSITION OF PROLONGED SURVIVAL, CONTAINING CYSTEMINE OR ITS SALT
EA201592297A1 (en) AGOMELATIN COMPOSITIONS CONTAINING AGOMELATIN IN THE FORM OF CRYSTALS
RU2015122882A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES
MX2018003890A (en) Pharmaceutical compositions containing a muscle relaxant and a non-steroidal anti-inflammatory drug (nsaid).
EA201792170A1 (en) INDOLA DERIVATIVES
MX2018008443A (en) Pharmaceutical composition comprising nebivolol with improved dissolution rate.
EA201691763A1 (en) STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20161223